A Dietary Study for People With Multiple Myeloma
-
- STATUS
- Not Recruiting
-
- End date
- Nov 11, 2028
-
- participants needed
- 220
-
- sponsor
- Memorial Sloan Kettering Cancer Center
Updated on 12 February 2026
Summary
The purpose of the study is to find out whether a high-fiber plant-based diet can improve treatment response or quality of life for people with multiple myeloma receiving standard induction chemotherapy with daratumumab (or isatuximab), lenalidomide, bortezomib, and dexamethasone (DRVd). The researchers will measure quality of life by having participants complete questionnaires.
Details
| Condition | Multiple Myeloma |
|---|---|
| Age | 18years or above |
| Clinical Study Identifier | NCT07226609 |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Modified on | 12 February 2026 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.